Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP)
Definition
Disorders due to use of dissociative drugs including ketamine and phencyclidine (PCP) are characterised by the pattern and consequences of dissociative drug use. Dissociative drugs include ketamine and PCP and their (comparatively rare) chemical analogues. Ketamine is an intravenous anaesthetic widely used in low- and middle-income countries, particularly in Africa, and in emergency situations. Ketamine is also undergoing evaluation for treatment of some mental disorders (e.g., treatment resistant Depressive Disorders). It is also a widespread drug of nonmedical use in many countries and may be taken by the oral or nasal routes or injected. It produces a sense of euphoria but depending on the dose, emergent hallucinations and dissociation are recognised as unpleasant side effects. Phencyclidine has a more restricted worldwide distribution and also has euphoric and dissociative effects. Its use may result in bizarre behaviour uncharacteristic for the individual, including self-harm. Dissociative Drug Dependence is described but a withdrawal syndrome is not recognized by most authorities. Several Dissociative Drug-Induced Mental Disorders are recognised.
Exclusions
9 subordinate codes
6C4D.0Episode of harmful use of dissociative drugs including ketamine or PCP6C4D.1Harmful pattern of use of dissociative drugs, including ketamine or PCP6C4D.2Dissociative drug dependence including ketamine or PCP6C4D.3Dissociative drug intoxication including Ketamine or PCP6C4D.4Dissociative drug-induced delirium including ketamine or PCP6C4D.5Dissociative drug-induced psychotic disorder including ketamine or PCP6C4D.6Certain specified dissociative drug-induced mental or behavioural disorders, including ketamine or phencyclidine (PCP)4B4YOther specified diseases of the immune system4B4ZDiseases of the immune system, unspecified
Nearby in Disorders due to substance use
6C40Disorders due to use of alcohol6C41Disorders due to use of cannabis6C42Disorders due to use of synthetic cannabinoids6C43Disorders due to use of opioids6C44Disorders due to use of sedatives, hypnotics or anxiolytics6C45Disorders due to use of cocaine6C46Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone6C47Disorders due to use of synthetic cathinones